Biphasic calcium phosphate microparticles for bone formation: Benefits of combination with blood clot

Tissue Engineering - Part A

Volumn 16, Issue 11, 2010, Pages 3495-3505

  Balaguer, Thierry ^a,b   Boukhechba, Florian ^a   Clavé, Arnaud ^a   Bouvet Gerbettaz, Sébastien ^a   Trojani, Christophe ^a,c   Michiels, Jean François ^d   Laugier, Jean Pierre ^e   Bouler, Jean Michel ^f   Carle, Georges F ^a   Scimeca, Jean Claude ^a   Rochet, Nathalie ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b University Hospital of Nice University of Nice Sophia Antipolis   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d PASTEUR HOSPITAL   (France)

^e Universite Co te d'Azur Parc Valrose   (France)

^f UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; BONE; DEFECTS; DENTAL PROSTHESES; PHOSPHATES;

BIPHASIC CALCIUM PHOSPHATES; BLOOD CLOTS; BONE DEFECT; BONE FORMATION; BONE SUBSTITUTES; COMPOSITE BIOMATERIALS; FILLING IN; MICRO-PARTICLES; OPEN POROSITY; ORTHOPEDIC SURGERY; OSTEOGENIC; OSTEOINDUCTIVE PROPERTIES; SEGMENTAL BONE DEFECT;

CALCIUM PHOSPHATE;

RATTUS;

CALCIUM PHOSPHATE;

ANIMAL; ARTICLE; BLOOD CELL; BLOOD CLOTTING; BONE DEVELOPMENT; CHEMISTRY; DRUG EFFECT; FEASIBILITY STUDY; FEMUR; IMPLANTATION; METABOLISM; MOUSE; PARTICLE SIZE; PATHOLOGY; RADIOGRAPHY; RAT; SUBCUTANEOUS TISSUE;

ANIMALS; BLOOD CELLS; BLOOD COAGULATION; CALCIUM PHOSPHATES; FEASIBILITY STUDIES; FEMUR; MICE; OSTEOGENESIS; PARTICLE SIZE; PROSTHESIS IMPLANTATION; RATS; SUBCUTANEOUS TISSUE;

EID: 78149261830     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0227     Document Type: Article

References (43)

1. Aulakh, T.S., Jayasekera, N., Kuiper, J.H., and Richardson, J.B. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty. Biomaterials 30, 1732, 2009.
2. Cavagna, R., Daculsi, G., and Bouler, J.M. Macroporous calcium phosphate ceramic: a prospective study of 106 cases in lumbar spinal fusion. J Long Term Eff Med Implants 9, 403, 1999.
3. De Long, W.G., Jr., Einhorn, T.A., Koval, K., McKee, M., Smith, W., Sanders, R., et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 89, 649, 2007.
4. Ransford, A.O., Morley, T., Edgar, M.A., Webb, P., Passuti, N., Chopin, D., et al. Synthetic porous ceramic compared with autograft in scoliosis surgery. A prospective, randomized study of 341 patients. J Bone Joint Surg Br 80, 13, 1998.
5. Baroth, S., Bourges, X., Goyenvalle, E., Aguado, E., and Da-culsi, G. Injectable biphasic calcium phosphate bioceramic: The HYDROS concept. Biomed Mater Eng 19, 71, 2009.
6. Fellah, B.H., Josselin, N., Chappard, D., Weiss, P., and Layrolle, P. Inflammatory reaction in rats muscle after implantation of biphasic calcium phosphate micro particles. J Mater Sci Mater Med 18, 287, 2007.
7. Mankani, M.H., Kuznetsov, S.A., Fowler, B., Kingman, A., and Robey, P.G. In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72, 96, 2001.
8. Mankani, M.H., Kuznetsov, S.A., Marshall, G.W., and Ro-bey, P.G. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14, 1949, 2008.
9. Bourges, X., Weiss, P., Daculsi, G., and Legeay, G. Synthesis and general properties of silated-hydroxypropyl methylcel-lulose in prospect of biomedical use. Adv Colloid Interface Sci 99, 215, 2002.
10. Trojani, C., Weiss, P., Michiels, J.F., Vinatier, C., Guicheux, J., Daculsi, G., et al. Three-dimensional culture and differentiation of human osteogenic cells in an injectable hydro-xypropylmethylcellulose hydrogel. Biomaterials 26, 5509, 2005.
11. Vinatier, C., Magne, D., Weiss, P., Trojani, C., Rochet, N., Carle, G.F., et al. A silanized hydroxypropyl methylcellulose hydrogel for the three-dimensional culture of chondrocytes. Biomaterials 26, 6643, 2005.
12. Daculsi, G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 19, 1473, 1998.
13. Gauthier, O., Boix, D., Grimandi, G., Aguado, E., Bouler, J.M., Weiss, P., et al. A new injectable calcium phosphate biomaterial for immediate bone filling of extraction sockets: a preliminary study in dogs. J Periodontol 70, 375, 1999.
14. Weiss, P., Layrolle, P., Clergeau, L.P., Enckel, B., Pilet, P., Amouriq, Y., et al. The safety and efficacy of an injectable bone substitute in dental sockets demonstrated in a human clinical trial. Biomaterials 28, 3295, 2007.
15. Fellah, B.H., Weiss, P., Gauthier, O., Rouillon, T., Pilet, P., Daculsi, G., et al. Bone repair using a new injectable self-crosslinkable bone substitute. J Orthop Res 24, 628, 2006.
16. Trojani, C., Boukhechba, F., Scimeca, J.C., Vandenbos, F., Michiels, J.F., Daculsi, G., et al. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydro-gel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 27, 3256, 2006.
17. Weiss, P., Obadia, L., Magne, D., Bourges, X., Rau, C., Weitkamp, T., et al. Synchrotron X-ray microtomography (on a micron scale) provides three-dimensional imaging representation of bone ingrowth in calcium phosphate biomate-rials. Biomaterials 24, 4591, 2003.
18. Daculsi, G., Uzel, A.P., Weiss, P., Goyenvalle, E., and Aguado, E. Developments in injectable multiphasic bioma-terials. The performance of microporous biphasic calcium phosphate granules and hydrogels. J Mater Sci Mater Med 21, 855, 2010.
19. Dupraz, A., Delecrin, J., Moreau, A., Pilet, P., and Passuti, N. Long-term bone response to particulate injectable ceramic. J Biomed Mater Res 42, 368, 1998.
20. Boukhechba, F., Balaguer, T., Michiels, J.F., Ackermann, K., Quincey, D., Bouler, J.M., et al. Human primary osteocyte differentiation in a 3D culture system. J Bone Miner Res 24, 1927, 2009.
21. Pioletti, D.P., Takei, H., Lin, T., Van Landuyt, P., Ma, Q.J., Kwon, S.Y., et al. The effects of calcium phosphate cement particles on osteoblast functions. Biomaterials 21, 1103, 2000.
22. Fellah, B.H., Delorme, B., Sohier, J., Magne, D., Hardouin, P., and Layrolle, P. Macrophage and osteoblast responses to biphasic calcium phosphate microparticles. J Biomed Mater Res A 93, 1588, 2010.
23. Bootle-Wilbraham,C.A., Tazzyman, S., Thompson, W.D., Stirk, C.M., and Lewis, C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4, 269, 2001.
24. Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., McDonagh, J., and Dvorak, A.M. Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57, 673, 1987.
25. Geer, D.J., Swartz, D.D., and Andreadis, S.T. Fibrin promotes migration in a three-dimensional in vitro model of wound regeneration. Tissue Eng 8, 787, 2002.
26. Ponte, A.L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25, 1737, 2007.
27. Thibault, M.M., Hoemann, C.D., and Buschmann, M.D. Fi-bronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 16, 489, 2007.
28. Thompson, W.D., Smith, E.B., Stirk, C.M., Marshall, F.I., Stout, A.J., and Kocchar, A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 168, 47, 1992.
29. Torigoe, I., Sotome, S., Tsuchiya, A., Yoshii, T., Maehara, H., Sugata, Y., et al. Bone regeneration with autologous plasma, bone marrow stromal cells, and porous beta-tricalcium phosphate in nonhuman primates. Tissue Eng Part A 15, 1489, 2009.
30. Kolar, P., Schmidt-Bleek, K., Schell, H., Gaber, T., Toben, D., Schmidtmaier, G., et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 16, 427, 2010.
31. Seybold, D., Schildhauer, T.A., Gessmann, J., Muhr, G., Koller, M., and Roetman, B. Osteogenic differentiation of human mesenchymal stromal cells is promoted by a leukocytes containing fibrin matrix. Langenbecks Arch Surg 395, 719, 2010.
32. Tsiridis, E., Upadhyay, N., and Giannoudis, P. Molecular aspects of fracture healing: which are the important molecules? Injury 38 Suppl 1, S11, 2007.
33. Kasten, P., Vogel, J., Geiger, F., Niemeyer, P., Luginbuhl, R., and Szalay, K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29, 3983, 2008.
34. Kawasumi, M., Kitoh, H., Siwicka, K.A., and Ishiguro, N. The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br 90, 966, 2008.
35. de Oliveira Filho, M.A., Nassif, P.A., Malafaia, O., Ribas Filho, J.M., Ribas, C.A., Camacho, A.C., et al. Effects of a highly concentrated platelet-rich plasma on the bone repair using non-critical defects in the calvaria of rabbits. Acta Cir Bras 25, 28, 2010.
36. Griffin, X.L., Smith, C.M., and Costa, M.L. The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury 40, 158, 2009.
37. Nikolidakis, D., van den Dolder, J., Wolke, J.G., Stoelinga, P.J., and Jansen, J.A. The effect of platelet-rich plasma on the bone healing around calcium phosphate-coated and non-coated oral implants in trabecular bone. Tissue Eng 12, 2555, 2006.
38. Dominici, M., Pritchard, C., Garlits, J.E., Hofmann, T.J., Persons, D.A., and Horwitz, E.M. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci \USA 101, 11761, 2004.
39. Eghbali-Fatourechi, G.Z., Lamsam, J., Fraser, D., Nagel, D., Riggs, B.L., and Khosla, S. Circulating osteoblast-lineage cells in humans. N Engl J Med 352, 1959, 2005.
40. Otsuru, S., Tamai, K., Yamazaki, T., Yoshikawa, H., and Kaneda, Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26, 223, 2008.
41. Einhorn, T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355 Suppl, S7, 1998.
42. Park, S.H., Silva, M., Bahk, W.J., McKellop, H., and Lieber-man, J.R. Effect of repeated irrigation and debridement on fracture healing in an animal model. J Orthop Res 20, 1197, 2002.
43. Mizuno, K., Mineo, K., Tachibana, T., Sumi, M., Matsu-bara, T., and Hirohata, K. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J Bone Joint Surg Br 72, 822, 1990.